United States Avian Influenza Vaccines Market Report & Forecast 2021-2027

United States Avian Influenza Vaccines Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Avian Influenza Vaccines Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Avian Influenza Vaccines Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Avian Influenza Vaccines Overall Market Size
2.1 United States Avian Influenza Vaccines Market Size: 2021 VS 2027
2.2 United States Avian Influenza Vaccines Revenue, Prospects & Forecasts: 2016-2027
2.3 United States Avian Influenza Vaccines Sales: 2016-2027
3 Company Landscape
3.1 Top Avian Influenza Vaccines Players in United States Market
3.2 Top United States Avian Influenza Vaccines Companies Ranked by Revenue
3.3 United States Avian Influenza Vaccines Revenue by Companies
3.4 United States Avian Influenza Vaccines Sales by Companies
3.5 United States Avian Influenza Vaccines Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Avian Influenza Vaccines Companies in United States Market, by Revenue in 2020
3.7 Manufacturers Avian Influenza Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Avian Influenza Vaccines Players in United States Market
3.8.1 List of Tier 1 Avian Influenza Vaccines Companies in United States
3.8.2 List of Tier 2 and Tier 3 Avian Influenza Vaccines Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Avian Influenza Vaccines Market Size Markets, 2021 & 2027
4.1.2 H5+H7 Avian Influenza Vaccines
4.1.3 H9 Avian Influenza Vaccines
4.2 By Type - United States Avian Influenza Vaccines Revenue & Forecasts
4.2.1 By Type - United States Avian Influenza Vaccines Revenue, 2016-2021
4.2.2 By Type - United States Avian Influenza Vaccines Revenue, 2022-2027
4.2.3 By Type - United States Avian Influenza Vaccines Revenue Market Share, 2016-2027
4.3 By Type - United States Avian Influenza Vaccines Sales & Forecasts
4.3.1 By Type - United States Avian Influenza Vaccines Sales, 2016-2021
4.3.2 By Type - United States Avian Influenza Vaccines Sales, 2022-2027
4.3.3 By Type - United States Avian Influenza Vaccines Sales Market Share, 2016-2027
4.4 By Type - United States Avian Influenza Vaccines Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Avian Influenza Vaccines Market Size, 2021 & 2027
5.1.2 Chicken Avian Influenza Vaccines
5.1.3 Duck & Goose Avian Influenza Vaccines
5.1.4 Other
5.2 By Application - United States Avian Influenza Vaccines Revenue & Forecasts
5.2.1 By Application - United States Avian Influenza Vaccines Revenue, 2016-2021
5.2.2 By Application - United States Avian Influenza Vaccines Revenue, 2022-2027
5.2.3 By Application - United States Avian Influenza Vaccines Revenue Market Share, 2016-2027
5.3 By Application - United States Avian Influenza Vaccines Sales & Forecasts
5.3.1 By Application - United States Avian Influenza Vaccines Sales, 2016-2021
5.3.2 By Application - United States Avian Influenza Vaccines Sales, 2022-2027
5.3.3 By Application - United States Avian Influenza Vaccines Sales Market Share, 2016-2027
5.4 By Application - United States Avian Influenza Vaccines Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 Merial
6.1.1 Merial Corporation Information
6.1.2 Merial Overview
6.1.3 Merial Avian Influenza Vaccines Sales and Revenue in United States Market (2016-2021)
6.1.4 Merial Avian Influenza Vaccines Product Description
6.1.5 Merial Recent Developments
6.2 QYH Biotech
6.2.1 QYH Biotech Corporation Information
6.2.2 QYH Biotech Overview
6.2.3 QYH Biotech Avian Influenza Vaccines Sales and Revenue in United States Market (2016-2021)
6.2.4 QYH Biotech Avian Influenza Vaccines Product Description
6.2.5 QYH Biotech Recent Developments
6.3 DHN
6.3.1 DHN Corporation Information
6.3.2 DHN Overview
6.3.3 DHN Avian Influenza Vaccines Sales and Revenue in United States Market (2016-2021)
6.3.4 DHN Avian Influenza Vaccines Product Description
6.3.5 DHN Recent Developments
6.4 HVRI
6.4.1 HVRI Corporation Information
6.4.2 HVRI Overview
6.4.3 HVRI Avian Influenza Vaccines Sales and Revenue in United States Market (2016-2021)
6.4.4 HVRI Avian Influenza Vaccines Product Description
6.4.5 HVRI Recent Developments
6.5 CEVA
6.5.1 CEVA Corporation Information
6.5.2 CEVA Overview
6.5.3 CEVA Avian Influenza Vaccines Sales and Revenue in United States Market (2016-2021)
6.5.4 CEVA Avian Influenza Vaccines Product Description
6.5.5 CEVA Recent Developments
6.6 Elanco (Lohmann )
6.6.1 Elanco (Lohmann ) Corporation Information
6.6.2 Elanco (Lohmann ) Overview
6.6.3 Elanco (Lohmann ) Avian Influenza Vaccines Sales and Revenue in United States Market (2016-2021)
6.6.4 Elanco (Lohmann ) Avian Influenza Vaccines Product Description
6.6.5 Elanco (Lohmann ) Recent Developments
6.7 Yebio
6.7.1 Yebio Corporation Information
6.7.2 Yebio Overview
6.7.3 Yebio Avian Influenza Vaccines Sales and Revenue in United States Market (2016-2021)
6.7.4 Yebio Avian Influenza Vaccines Product Description
6.7.5 Yebio Recent Developments
6.8 Zoetis
6.8.1 Zoetis Corporation Information
6.8.2 Zoetis Overview
6.8.3 Zoetis Avian Influenza Vaccines Sales and Revenue in United States Market (2016-2021)
6.8.4 Zoetis Avian Influenza Vaccines Product Description
6.8.5 Zoetis Recent Developments
6.9 FATRO
6.9.1 FATRO Corporation Information
6.9.2 FATRO Overview
6.9.3 FATRO Avian Influenza Vaccines Sales and Revenue in United States Market (2016-2021)
6.9.4 FATRO Avian Influenza Vaccines Product Description
6.9.5 FATRO Recent Developments
6.10 Kyoto Biken
6.10.1 Kyoto Biken Corporation Information
6.10.2 Kyoto Biken Overview
6.10.3 Kyoto Biken Avian Influenza Vaccines Sales and Revenue in United States Market (2016-2021)
6.10.4 Kyoto Biken Avian Influenza Vaccines Product Description
6.10.5 Kyoto Biken Recent Developments
6.11 CAVAC
6.11.1 CAVAC Corporation Information
6.11.2 CAVAC Overview
6.11.3 CAVAC Avian Influenza Vaccines Sales and Revenue in United States Market (2016-2021)
6.11.4 CAVAC Avian Influenza Vaccines Product Description
6.11.5 CAVAC Recent Developments
6.12 Ringpu Biology
6.12.1 Ringpu Biology Corporation Information
6.12.2 Ringpu Biology Overview
6.12.3 Ringpu Biology Avian Influenza Vaccines Sales and Revenue in United States Market (2016-2021)
6.12.4 Ringpu Biology Avian Influenza Vaccines Product Description
6.12.5 Ringpu Biology Recent Developments
6.13 Vaksindo
6.13.1 Vaksindo Corporation Information
6.13.2 Vaksindo Overview
6.13.3 Vaksindo Avian Influenza Vaccines Sales and Revenue in United States Market (2016-2021)
6.13.4 Vaksindo Avian Influenza Vaccines Product Description
6.13.5 Vaksindo Recent Developments
6.14 ChengDu Tecbond
6.14.1 ChengDu Tecbond Corporation Information
6.14.2 ChengDu Tecbond Overview
6.14.3 ChengDu Tecbond Avian Influenza Vaccines Sales and Revenue in United States Market (2016-2021)
6.14.4 ChengDu Tecbond Avian Influenza Vaccines Product Description
6.14.5 ChengDu Tecbond Recent Developments
6.15 Sindh Poultry Vaccine Centre
6.15.1 Sindh Poultry Vaccine Centre Corporation Information
6.15.2 Sindh Poultry Vaccine Centre Overview
6.15.3 Sindh Poultry Vaccine Centre Avian Influenza Vaccines Sales and Revenue in United States Market (2016-2021)
6.15.4 Sindh Poultry Vaccine Centre Avian Influenza Vaccines Product Description
6.15.5 Sindh Poultry Vaccine Centre Recent Developments
6.16 Merck Animal Health
6.16.1 Merck Animal Health Corporation Information
6.16.2 Merck Animal Health Overview
6.16.3 Merck Animal Health Avian Influenza Vaccines Sales and Revenue in United States Market (2016-2021)
6.16.4 Merck Animal Health Avian Influenza Vaccines Product Description
6.16.5 Merck Animal Health Recent Developments
6.17 Medion
6.17.1 Medion Corporation Information
6.17.2 Medion Overview
6.17.3 Medion Avian Influenza Vaccines Sales and Revenue in United States Market (2016-2021)
6.17.4 Medion Avian Influenza Vaccines Product Description
6.17.5 Medion Recent Developments
6.18 Avimex Animal Health
6.18.1 Avimex Animal Health Corporation Information
6.18.2 Avimex Animal Health Overview
6.18.3 Avimex Animal Health Avian Influenza Vaccines Sales and Revenue in United States Market (2016-2021)
6.18.4 Avimex Animal Health Avian Influenza Vaccines Product Description
6.18.5 Avimex Animal Health Recent Developments
6.19 JOVAC
6.19.1 JOVAC Corporation Information
6.19.2 JOVAC Overview
6.19.3 JOVAC Avian Influenza Vaccines Sales and Revenue in United States Market (2016-2021)
6.19.4 JOVAC Avian Influenza Vaccines Product Description
6.19.5 JOVAC Recent Developments
6.20 Bio-Labs
6.20.1 Bio-Labs Corporation Information
6.20.2 Bio-Labs Overview
6.20.3 Bio-Labs Avian Influenza Vaccines Sales and Revenue in United States Market (2016-2021)
6.20.4 Bio-Labs Avian Influenza Vaccines Product Description
6.20.5 Bio-Labs Recent Developments
7 United States Avian Influenza Vaccines Production Capacity, Analysis
7.1 United States Avian Influenza Vaccines Production Capacity, 2016-2027
7.2 Avian Influenza Vaccines Production Capacity of Key Manufacturers in United States Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Avian Influenza Vaccines Supply Chain Analysis
9.1 Avian Influenza Vaccines Industry Value Chain
9.2 Avian Influenza Vaccines Upstream Market
9.3 Avian Influenza Vaccines Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Avian Influenza Vaccines Distributors and Sales Agents in United States Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of Tables
Table 1. Key Players of Avian Influenza Vaccines in United States Market
Table 2. Top Avian Influenza Vaccines Players in United States Market, Ranking by Revenue (2019)
Table 3. United States Avian Influenza Vaccines Revenue by Companies, (US$, Mn), 2016-2021
Table 4. United States Avian Influenza Vaccines Revenue Share by Companies, 2016-2021
Table 5. United States Avian Influenza Vaccines Sales by Companies, (M Doses), 2016-2021
Table 6. United States Avian Influenza Vaccines Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Avian Influenza Vaccines Price (2016-2021) & (USD/K Doses)
Table 8. Manufacturers Avian Influenza Vaccines Product Type
Table 9. List of Tier 1 Avian Influenza Vaccines Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Avian Influenza Vaccines Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of H5+H7 Avian Influenza Vaccines
Table 12. Major Manufacturers of H9 Avian Influenza Vaccines
Table 13. By Type - United States Avian Influenza Vaccines Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - United States Avian Influenza Vaccines Revenue (US$, Mn), 2016-2021
Table 15. By Type - United States Avian Influenza Vaccines Revenue (US$, Mn), 2022-2027
Table 16. By Type - United States Avian Influenza Vaccines Sales (M Doses), 2016-2021
Table 17. By Type - United States Avian Influenza Vaccines Sales (M Doses), 2022-2027
Table 18. By Application - United States Avian Influenza Vaccines Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - United States Avian Influenza Vaccines Revenue (US$, Mn), 2016-2021
Table 20. By Application - United States Avian Influenza Vaccines Revenue (US$, Mn), 2022-2027
Table 21. By Application - United States Avian Influenza Vaccines Sales (M Doses), 2016-2021
Table 22. By Application - United States Avian Influenza Vaccines Sales (M Doses), 2022-2027
Table 23. Merial Corporation Information
Table 24. Merial Description and Major Businesses
Table 25. Merial Avian Influenza Vaccines Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/K Doses) (2016-2021)
Table 26. Merial Avian Influenza Vaccines Product
Table 27. Merial Recent Developments
Table 28. QYH Biotech Corporation Information
Table 29. QYH Biotech Description and Major Businesses
Table 30. QYH Biotech Avian Influenza Vaccines Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/K Doses) (2016-2021)
Table 31. QYH Biotech Avian Influenza Vaccines Product
Table 32. QYH Biotech Recent Developments
Table 33. DHN Corporation Information
Table 34. DHN Description and Major Businesses
Table 35. DHN Avian Influenza Vaccines Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/K Doses) (2016-2021)
Table 36. DHN Avian Influenza Vaccines Product
Table 37. DHN Recent Developments
Table 38. HVRI Corporation Information
Table 39. HVRI Description and Major Businesses
Table 40. HVRI Avian Influenza Vaccines Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/K Doses) (2016-2021)
Table 41. HVRI Avian Influenza Vaccines Product
Table 42. HVRI Recent Developments
Table 43. CEVA Corporation Information
Table 44. CEVA Description and Major Businesses
Table 45. CEVA Avian Influenza Vaccines Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/K Doses) (2016-2021)
Table 46. CEVA Avian Influenza Vaccines Product
Table 47. CEVA Recent Developments
Table 48. Elanco (Lohmann ) Corporation Information
Table 49. Elanco (Lohmann ) Description and Major Businesses
Table 50. Elanco (Lohmann ) Avian Influenza Vaccines Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/K Doses) (2016-2021)
Table 51. Elanco (Lohmann ) Avian Influenza Vaccines Product
Table 52. Elanco (Lohmann ) Recent Developments
Table 53. Yebio Corporation Information
Table 54. Yebio Description and Major Businesses
Table 55. Yebio Avian Influenza Vaccines Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/K Doses) (2016-2021)
Table 56. Yebio Avian Influenza Vaccines Product
Table 57. Yebio Recent Developments
Table 58. Zoetis Corporation Information
Table 59. Zoetis Description and Major Businesses
Table 60. Zoetis Avian Influenza Vaccines Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/K Doses) (2016-2021)
Table 61. Zoetis Avian Influenza Vaccines Product
Table 62. Zoetis Recent Developments
Table 63. FATRO Corporation Information
Table 64. FATRO Description and Major Businesses
Table 65. FATRO Avian Influenza Vaccines Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/K Doses) (2016-2021)
Table 66. FATRO Avian Influenza Vaccines Product
Table 67. FATRO Recent Developments
Table 68. Kyoto Biken Corporation Information
Table 69. Kyoto Biken Description and Major Businesses
Table 70. Kyoto Biken Avian Influenza Vaccines Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/K Doses) (2016-2021)
Table 71. Kyoto Biken Avian Influenza Vaccines Product
Table 72. Kyoto Biken Recent Developments
Table 73. CAVAC Corporation Information
Table 74. CAVAC Description and Major Businesses
Table 75. CAVAC Avian Influenza Vaccines Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/K Doses) (2016-2021)
Table 76. CAVAC Avian Influenza Vaccines Product
Table 77. CAVAC Recent Developments
Table 78. Ringpu Biology Corporation Information
Table 79. Ringpu Biology Description and Major Businesses
Table 80. Ringpu Biology Avian Influenza Vaccines Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/K Doses) (2016-2021)
Table 81. Ringpu Biology Avian Influenza Vaccines Product
Table 82. Ringpu Biology Recent Developments
Table 83. Vaksindo Corporation Information
Table 84. Vaksindo Description and Major Businesses
Table 85. Vaksindo Avian Influenza Vaccines Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/K Doses) (2016-2021)
Table 86. Vaksindo Avian Influenza Vaccines Product
Table 87. Vaksindo Recent Developments
Table 88. ChengDu Tecbond Corporation Information
Table 89. ChengDu Tecbond Description and Major Businesses
Table 90. ChengDu Tecbond Avian Influenza Vaccines Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/K Doses) (2016-2021)
Table 91. ChengDu Tecbond Avian Influenza Vaccines Product
Table 92. ChengDu Tecbond Recent Developments
Table 93. Sindh Poultry Vaccine Centre Corporation Information
Table 94. Sindh Poultry Vaccine Centre Description and Major Businesses
Table 95. Sindh Poultry Vaccine Centre Avian Influenza Vaccines Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/K Doses) (2016-2021)
Table 96. Sindh Poultry Vaccine Centre Avian Influenza Vaccines Product
Table 97. Sindh Poultry Vaccine Centre Recent Developments
Table 98. Merck Animal Health Corporation Information
Table 99. Merck Animal Health Description and Major Businesses
Table 100. Merck Animal Health Avian Influenza Vaccines Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/K Doses) (2016-2021)
Table 101. Merck Animal Health Avian Influenza Vaccines Product
Table 102. Merck Animal Health Recent Developments
Table 103. Medion Corporation Information
Table 104. Medion Description and Major Businesses
Table 105. Medion Avian Influenza Vaccines Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/K Doses) (2016-2021)
Table 106. Medion Avian Influenza Vaccines Product
Table 107. Medion Recent Developments
Table 108. Avimex Animal Health Corporation Information
Table 109. Avimex Animal Health Description and Major Businesses
Table 110. Avimex Animal Health Avian Influenza Vaccines Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/K Doses) (2016-2021)
Table 111. Avimex Animal Health Avian Influenza Vaccines Product
Table 112. Avimex Animal Health Recent Developments
Table 113. JOVAC Corporation Information
Table 114. JOVAC Description and Major Businesses
Table 115. JOVAC Avian Influenza Vaccines Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/K Doses) (2016-2021)
Table 116. JOVAC Avian Influenza Vaccines Product
Table 117. JOVAC Recent Developments
Table 118. Bio-Labs Corporation Information
Table 119. Bio-Labs Description and Major Businesses
Table 120. Bio-Labs Avian Influenza Vaccines Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/K Doses) (2016-2021)
Table 121. Bio-Labs Avian Influenza Vaccines Product
Table 122. Bio-Labs Recent Developments
Table 123. Avian Influenza Vaccines Production Capacity (M Doses) of Key Manufacturers in United States Market, 2019-2021 (M Doses)
Table 124. United States Avian Influenza Vaccines Capacity Market Share of Key Manufacturers, 2019-2021
Table 125. Avian Influenza Vaccines Market Opportunities & Trends in United States Market
Table 126. Avian Influenza Vaccines Market Drivers in United States Market
Table 127. Avian Influenza Vaccines Market Restraints in United States Market
Table 128. Avian Influenza Vaccines Raw Materials
Table 129. Avian Influenza Vaccines Raw Materials Suppliers in United States Market
Table 130. Typical Avian Influenza Vaccines Downstream
Table 131. Avian Influenza Vaccines Downstream Clients in United States Market
Table 132. Avian Influenza Vaccines Distributors and Sales Agents in United States Market
List of Figures
Figure 1. Avian Influenza Vaccines Product Picture
Figure 2. Avian Influenza Vaccines Segment by Type
Figure 3. Avian Influenza Vaccines Segment by Application
Figure 4. United States Avian Influenza Vaccines Market Overview: 2020
Figure 5. United States Avian Influenza Vaccines Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. United States Avian Influenza Vaccines Revenue, 2016-2027 (US$, Mn)
Figure 7. Avian Influenza Vaccines Sales in United States Market: 2016-2027 (M Doses)
Figure 8. The Top 3 and 5 Players Market Share by Avian Influenza Vaccines Revenue in 2020
Figure 9. H5+H7 Avian Influenza Vaccines Product Picture
Figure 10. H9 Avian Influenza Vaccines Product Picture
Figure 11. By Type - United States Avian Influenza Vaccines Sales Market Share, 2016-2027
Figure 12. By Type - United States Avian Influenza Vaccines Revenue Market Share, 2016-2027
Figure 13. By Type - United States Avian Influenza Vaccines Price (USD/K Doses), 2016-2027
Figure 14. Chicken Avian Influenza Vaccines
Figure 15. Duck & Goose Avian Influenza Vaccines
Figure 16. Other
Figure 17. By Application - United States Avian Influenza Vaccines Sales Market Share, 2016-2027
Figure 18. By Application - United States Avian Influenza Vaccines Revenue Market Share, 2016-2027
Figure 19. By Application - United States Avian Influenza Vaccines Price (USD/K Doses), 2016-2027
Figure 20. Merial Avian Influenza Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 21. QYH Biotech Avian Influenza Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 22. DHN Avian Influenza Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. HVRI Avian Influenza Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. CEVA Avian Influenza Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. Elanco (Lohmann ) Avian Influenza Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. Yebio Avian Influenza Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. Zoetis Avian Influenza Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. FATRO Avian Influenza Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 29. Kyoto Biken Avian Influenza Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 30. CAVAC Avian Influenza Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 31. Ringpu Biology Avian Influenza Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 32. Vaksindo Avian Influenza Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 33. ChengDu Tecbond Avian Influenza Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 34. Sindh Poultry Vaccine Centre Avian Influenza Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 35. Merck Animal Health Avian Influenza Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 36. Medion Avian Influenza Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 37. Avimex Animal Health Avian Influenza Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. JOVAC Avian Influenza Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Bio-Labs Avian Influenza Vaccines Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. United States Avian Influenza Vaccines Production Capacity (M Doses), 2016-2027
Figure 41. Avian Influenza Vaccines Industry Value Chain
Figure 42. Marketing Channels

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Encephalitis Vaccination Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 102

According to our LPI (LP Information) latest study, the global Encephalitis Vaccination market size was valued at US$ 1263.1 million in 2023. With growing demand in downstream market, the Encephalitis Vaccination is forecast to a readjusted size of US$ 1875.5 million by 2030 with a CAGR of 5.8% during review period. The research report highlights the growth potential of the global Encephalitis Vaccination market. Encephalitis Vaccination are expected to show stable growth in the future m......

Global Avian Influenza Vaccines Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 123

Market Overview of Global Avian Influenza Vaccines market: According to our latest research, the global Avian Influenza Vaccines market looks promising in the next 5 years. As of 2022, the global Avian Influenza Vaccines market was estimated at USD 933.69 million, and it's anticipated to reach USD 1586.45 million in 2028, with a CAGR of 9.24% during the forecast years. Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. ......

Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96

According to our LPI (LP Information) latest study, the global 23-Valent Pneumococcal Polysaccharide Vaccine market size was valued at US$ 1114.7 million in 2023. With growing demand in downstream market, the 23-Valent Pneumococcal Polysaccharide Vaccine is forecast to a readjusted size of US$ 2265.8 million by 2030 with a CAGR of 10.7% during review period. The research report highlights the growth potential of the global 23-Valent Pneumococcal Polysaccharide Vaccine market. 23-Valent P......

Global Avian Influenza Vaccines Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 155

According to our LPI (LP Information) latest study, the global Avian Influenza Vaccines market size was valued at US$ 928.4 million in 2023. With growing demand in downstream market, the Avian Influenza Vaccines is forecast to a readjusted size of US$ 1369 million by 2030 with a CAGR of 5.7% during review period. The research report highlights the growth potential of the global Avian Influenza Vaccines market. Avian Influenza Vaccines are expected to show stable growth in the future mark......

Global Encephalitis Vaccination Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 106

Market Overview of Global Encephalitis Vaccination market: According to our latest research, the global Encephalitis Vaccination market looks promising in the next 5 years. As of 2022, the global Encephalitis Vaccination market was estimated at USD 52963.61 million, and it's anticipated to reach USD 65320.29 million in 2028, with a CAGR of 3.56% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis......

Global Influenza Vaccine Market Research Report 2023

Published: 28-Dec-2023        Price: US 2900 Onwards        Pages: 96

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Influenza Vaccine market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Sanofi - CSL - GSK - Viatris - AstraZeneca - Hualan Bio - Changchun Institute of Biological - Sinovac - BCHT - Jiangsu G......

Global Japanese Encephalitis Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 117

Market Overview of Global Japanese Encephalitis Vaccine market: According to our latest research, the global Japanese Encephalitis Vaccine market looks promising in the next 5 years. As of 2022, the global Japanese Encephalitis Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysi......

Global Influenza Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 14-Dec-2023        Price: US 3380 Onwards        Pages: 103

Market Overview of Global Influenza Vaccine market: According to our latest research, the global Influenza Vaccine market looks promising in the next 5 years. As of 2022, the global Influenza Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Influenza vaccines, also known as flu shots or flu jabs, are vaccines that protect against infection by influenza viruses... ......

2023-2031 Report on Global Influenza Vaccine Market by Player, Region, Type, Application and Sales Channel

Published: 11-Dec-2023        Price: US 2500 Onwards        Pages: 107

This report studies the Influenza Vaccine market, covering market size for segment by type (Inactivated Vaccine, Live Attenuated Vaccine, etc.), by application (Pediatric, Adults, etc.), by sales channel (Direct Channel, Distribution Channel), by player (CSL, GSK, Sanofi, Mylan, AstraZeneca, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market for Influenza Vaccine from......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs